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ABSTRACT
Since its inception, cardiac pacing has made a significant advancement in cardiology. As
new therapies and devices emerge, the number of implantations is steadily increasing
which requires up-to-date clinical guidelines for management. Although advanced,
these mechanical devices often require maintenance and revisions to achieve optimal
performance. One of the most common deteriorations is lead failure.
In the case of lead failure requiring revision, new lead implant, or upgrading to a more
advanced pacing system, venous stenosis resulting in partial or complete obstruction
of the vessel can pose a real problem. This case series report introduces the technique
of percutaneous transluminal balloon venoplasty in the setting of venous stenosis as
an alternative to more invasive procedures such as lead extraction for lead revision or
device upgrade.
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INTRODUCTION
Artificial cardiac pacemakers have come a long way
since Albert S. Hyman’s external cardiac pacemaker
system in 1932. Major advancements in cardiac
pacing occurred in the 1950s, including the first
complete implantation of an epicardial pacing system
and a transvenous temporary pacing lead.1
With the invention of transvenous implantable
cardioverter-defibrillator (ICD) leads in the early
1980s, management of arrhythmias and heart failure
improved significantly.2-4 Over past several decades,
novel therapies have developed and, as a result, the
number of pacemaker implantations have steadily
increased. Furthermore, with the improvement
in technology, patients with older systems have
required upgrades to ICDs and/or dual and
biventricular pacing systems.5 In these procedures,
access to the subclavian veins is paramount to the
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success of the operation. However, as with any
procedure requiring central venous access and
insertion of leads, venous stenosis can occur.
Patients with venous stenosis rarely report significant
clinical symptoms due to the development of
adequate venous collateral circulation.6 Young,
active patients are more likely to be symptomatic.
Unfortunately, if a patient requires implantation of
additional leads, partial or complete venous stenosis
can impede and complicate the procedure.7
There are numerous solutions to this dilemma. These
solutions include: extracting one lead to gain access;
implant the new lead in the opposite side then
tunnel it to the same pocket; or implant epicardial
lead surgically.7 As an alternative to these invasive
and risky procedures for new lead implant, we
describe a less invasive technique in the setting of
venous stenosis: percutaneous transluminal balloon
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venoplasty.
CASE SERIES
Case I
A 74-year-old male with a history of recurrent
syncope related to hypotension caused by frequent
premature ventricular contractions (PVCs) and
bradycardia secondary to first-degree heart
block and bundle branch block underwent a dual
chamber pacemaker implantation. The patient was
on hemodialysis and met Class I indication for a
pacemaker implant.
The venography showed a complete obstruction
of the patient’s left subclavian and innominate

FIGURE 1A. Pre-venoplasty

veins (Figure 1A) which challenged the left-sided
access to the heart, rendering right-sided access
the alternative option for the implant procedure.
However, the patient had a failed arteriovenous
fistula (AVF) on the left arm for hemodialysis, which
resulted in a second AVF creation on the right arm,
and it was not advised to implant on the same
side of the fistula. The interventional cardiologist
was consulted to assess the possibility of patency
restoration of the left veins. Angioplasty was
successfully performed using an Evercross 9/150mm
balloon (Figures 1B and 1C). The transvenous
pacemaker implantation was subsequently
performed through the left subclavian vein, and
the leads were placed without any difficulties. This
resulted in a successful pacemaker implantation
while reserving the right AVF function.

FIGURE 1B. Venoplasty

FIGURE 1C. Venoplasty
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Case II
A 67-year-old female with a single chamber ICD
and a history of severe ischemic cardiomyopathy,
atrial fibrillation, and LBBB with wide QRS and
ventricular tachycardia underwent CRT-D upgrade
which required the addition of an LV lead. The preexisting generator previously implanted via left
infraclavicular vein was explanted to implant the
newer generator with more than one lead port.
The venous access was gained through the left
subclavian vein. However, attempts to advance
the wire beyond the innominate vein encountered

difficulties despite the use of multiple wires,
including the Wholey wire and the Glidewire. A
venogram showed a total obstruction in distal
innominate vein (Figure 2A).
An interventional radiologist was consulted
for a balloon venoplasty, which resulted in a
successful dilation of the vein (Figures 2B and 2C).
Subsequently, the wire was advanced through the
dilated left vein and the left ventricular lead placed.
Then, the right atrial lead was placed on the right
side of the heart which completed the upgrade
procedure.

FIGURE 2A. Pre-venoplasty

FIGURE 2B. Venoplasty

FIGURE 2C. Post-venoplasty
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Case III
A 77-year-old male with severe cardiomyopathy and
NYHA Class 3 CHF symptoms presented with a dual
chamber ICD that reached elective replacement
interval. The patient was scheduled to receive CRT-D
upgrade. The LV lead placement was indicated due
to cardiomyopathy, prominent PR prolongation
more than 300 ms, and V-pacing at 100% with QRS of
almost 200 ms.
The attempt to upgrade was unsuccessful because
the left subclavian vein was subtotally occluded
(Figure 3A). An interventional cardiologist was
consulted to dilate the occluded vessel. The right
femoral vein from below and the left accessory vein
from above were accessed without any difficulties,

and an angiogram was obtained through the
innominate vein and superior vena cava which
showed a clear occlusion of the left innominate vein.
The wire was advanced until it reached the right
atrium through a slender sheath that was introduced
via the left accessory vein access. A 5.0 balloon was
initially used followed by a 9/80 Mustang balloon
which was inflated for a total of 8 atmospheres for 2
minutes (Figure 3B).
A post-dilation angiogram showed a complete
resolution of stenosis throughout the course of
the innominate vein with 10% residual and no
immediate complications (Figure 3C). After the
procedure, EP cardiology proceeded with the CRT-D
generator change and LV lead implant on the same
side of pre-existing generator.

FIGURE 3A. Pre-venoplasty

FIGURE 3B. Venoplasty

FIGURE 3C. Post-venoplasty
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DISCUSSION
Transvenous introduction of the leads through
the subclavian vein is the most commonly used
technique for pacemaker or ICD device placement.
The leads are well known to be susceptible to
multiple different problems: fracture of the leads
from deterioration, insulation defects, connector
issues, and infections.1
In addition, the leads can cause deep venous
thrombosis or irritate the vessel wall at the site of
lead intersection which can result in development
of venous stenosis.1,8 Venous stenosis can be a
challenge for the operator if the patient requires the
implantation of new leads. Therefore, patency of
the accessible veins is a critical factor for procedural
success.5
In association with permanent transvenous
pacemaker electrodes, the incidence of partial
venous obstruction varies from 31% to 50% with
up to one-third of patients having total venous
occlusions9,10. In a recent prospective study, about
26% of patients with pacemakers or ICD systems
were found to have a total occlusion of the
subclavian or innominate vein, and up to 25% of
them have significant venous stenosis (>50%) with a
mean time of 6.2 years since implantation.5
Venous stenosis, a well-recognized complication
of pacemaker or ICD lead placement, can cause
perplexing situations during the lead revision or
replacement. Without doubt, total venous occlusion
proves to be more challenging and leaves the
operator with limited choices. In situations of total
venous occlusion, there are two main options: an
extraction of a functional lead in order to get access;
or an implantation of the lead on the opposite
side and then tunneling it to the pocket. Using the
opposite side may not be an option in the presence
of an AV fistula. It may be possible to get access
into the vein medial to the obstruction. Epicardial
implantation by a surgeon could be the last resort if a
ventricular lead is needed.7
A more recent technique is to use a leadless device
such as Micra for pacing the right ventricle. To bypass
the downfalls of these previously described solutions
to transvenous lead revision or device upgrade with
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venous stenosis, a new option that is gaining interest
is the successful dilatation of venous stenosis.
This technique avoids more invasive options.
Percutaneous transluminal balloon venoplasty can
be performed safely, provided the procedure is
performed by personnel with adequate training and
the necessary equipment is readily available. Lead
implant can take place the following day while the
patient remains anticoagulated with IV heparin to
prevent closure of the vein.
It has been established that in symptomatic cases
of venous stenosis resulting in superior vena cava
syndrome (SVC syndrome), an option to relieve
the symptoms is to place a stent in the area of
stenosis.11,12 In the cases described, these lesions
are found incidentally in asymptomatic patients.
Venoplasty is sufficient in dilating the vein to allow
for pacemaker lead revision.13 While stenting would
remain a potential option for venous stenosis
found when attempting pacemaker lead revision, it
would require the patients to also take antiplatelet
medication following the placing of the stent, which
could lead to further bleeding complications.
Although there are some potential risks associated
with percutaneous transluminal balloon venoplasty,
its benefits may outweigh the risks. This technique
can avoid proceeding with more invasive options
such as surgical access or using other veins with
potential future stenosis. Since veins have thinner
walls and are less elastic compared to arteries,
there is a possibility of rupturing the vein during
the balloon venoplasty procedure. This could result
in potential intrathoracic hematoma which may
require further invasive procedures for it to resolve.
While wiring a distal occlusion does not pose the
risk of cardiac tamponade, the complications of
pacemaker lead insertion are still present. The
incidence of complications with percutaneous
transluminal balloon venoplasty remains yet to be
defined. Moreover, the routine use of preoperative
venography prior to pacemaker lead revision is
recommended to detect significant occlusive venous
disease and to aid in determining the optimal route
of electrode placement and the type of operating
room as a hybrid room would be preferred when
extraction is needed.
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CONCLUSION

AUTHOR AFFILIATIONS

The adjunct use of antiplatelet agents and
anticoagulants has not been adequately studied
after venous stenting. Based upon the underlying
pathophysiology, extrapolation of results from
arterial interventions, and clinical experience, there
seems to be a role for these agents. Antiplatelet
agents would be most appropriate for patients with
primary vein lesions while anticoagulants would
have a greater role in post-thrombotic disease.14 In
a recent study, the current consensus is to utilize
anticoagulant therapy following venous stenting
while it lacks evidence with respect to the role of
antiplatelet agents.15 Given the lack of evidence
supporting the use of both antiplatelet agents and
anticoagulants, a careful assessment of the risks
and benefits in the individual patients would be
warranted.14
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Transluminal balloon venoplasty technique is an
option that can help avoid more invasive alternatives.
It also spares other veins as access, hence preventing
the potential for future stenosis. This option should
be considered before extraction of a functional lead
or attempting to get access on the contralateral
side. Although the incidence of complications of
venoplasty are still yet to be defined, its benefits may
outweigh the risks when compared to alternative
techniques for pacemaker lead revision in the setting
of venous stenosis.
ABBREVIATIONS
AF – Atrial fibrillation
CHF – Congestive Heart Failure
CRT – Cardiac Resynchronization Therapy
CS – Coronary Sinus
EF – Ejection Fraction
EP – Electrophysiology
ICD – Implantable Cardioverter-Defibrillator
LBBB – Left Branch Bundle Block
LV – Left Ventricle/Ventricular
MRI – Magnetic Resonance Imaging
NYHA – New York Heart Association
PVC – Premature Ventricular Contraction
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